BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2058468)

  • 1. The pharmacology of ebselen.
    Parnham MJ; Leyck S; Graf E; Dowling EJ; Blake DR
    Agents Actions; 1991 Jan; 32(1-2):4-9. PubMed ID: 2058468
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological activities and clinical potential of Ebselen.
    Parnham MJ
    Adv Exp Med Biol; 1990; 264():193-7. PubMed ID: 2244495
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure-activity relationships of a series of anti-inflammatory benzisoselenazolones (BISAs).
    Parnham MJ; Biedermann J; Bittner C; Dereu N; Leyck S; Wetzig H
    Agents Actions; 1989 Jun; 27(3-4):306-8. PubMed ID: 2801314
    [No Abstract]   [Full Text] [Related]  

  • 4. [Benzisoselenazolinones and their derivatives, a new series of anti-inflammatories and antioxidants].
    Renson M; Dereu N
    J Pharm Belg; 1990; 45(5):322-30. PubMed ID: 2086756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Horseradish peroxidase inhibition and antioxidant activity of ebselen and related organoselenium compounds.
    Mishra B; Priyadarsini KI; Mohan H; Mugesh G
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5334-8. PubMed ID: 16919452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reaction of ebselen with peroxynitrite.
    Masumoto H; Sies H
    Chem Res Toxicol; 1996; 9(1):262-7. PubMed ID: 8924601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds.
    Nogueira CW; Rocha JB
    Arch Toxicol; 2011 Nov; 85(11):1313-59. PubMed ID: 21720966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ51).
    Maiorino M; Roveri A; Coassin M; Ursini F
    Biochem Pharmacol; 1988 Jun; 37(11):2267-71. PubMed ID: 3377822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ebselen prevents inositol (1,4,5)-trisphosphate binding to its receptor.
    Dimmeler S; Brüne B; Ullrich V
    Biochem Pharmacol; 1991 Aug; 42(5):1151-3. PubMed ID: 1651731
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitogenic activity of selenoorganic compounds in human peripheral blood leukocytes.
    Czyrski JA; Inglot AD
    Experientia; 1991 Jan; 47(1):95-7. PubMed ID: 1999252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some aspects of cardiac antioxidant defence: Ebselen (PZ 51) treatment increases glutathione peroxidase activity in the rat heart.
    Hermenegildo C; Nies E; Monsalve E; Puertas FJ; Higueras V; Romero FJ
    Biochem Soc Trans; 1990 Dec; 18(6):1193-4. PubMed ID: 2088859
    [No Abstract]   [Full Text] [Related]  

  • 12. Ebselen has dehydroascorbate reductase and thioltransferase-like activities.
    Jung CH; Washburn MP; Wells WW
    Biochem Biophys Res Commun; 2002 Mar; 291(3):550-3. PubMed ID: 11855823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ebselen on IL-1-induced alterations in cartilage metabolism.
    Pratta MA; Ackerman NR; Arner EC
    Inflamm Res; 1998 Mar; 47(3):115-21. PubMed ID: 9562336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebselen affects calcium homeostasis in human platelets.
    Brüne B; Diewald B; Ullrich V
    Biochem Pharmacol; 1991 Jun; 41(12):1805-11. PubMed ID: 2039537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection by seleno-organic compound, Ebselen, against acute gastric mucosal injury induced by ischemia-reperfusion in rats.
    Ueda S; Yoshikawa T; Takahashi S; Naito Y; Oyamada H; Takemura T; Morita Y; Tanigawa T; Sugino S; Kondo M
    Adv Exp Med Biol; 1990; 264():187-90. PubMed ID: 2244494
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.
    Baldew GS; McVie JG; van der Valk MA; Los G; de Goeij JJ; Vermeulen NP
    Cancer Res; 1990 Nov; 50(21):7031-6. PubMed ID: 2208170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of rat hepatic microsomal electron transport chains by the selenium-containing anti-inflammatory agent Ebselen.
    Nagi MN; Laguna JC; Cook L; Cinti DL
    Arch Biochem Biophys; 1989 Feb; 269(1):264-71. PubMed ID: 2916842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions.
    Parnham MJ; Graf E
    Biochem Pharmacol; 1987 Oct; 36(19):3095-102. PubMed ID: 3311047
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute antiinflammatory and gastric effects of the seleno-organic compound ebselen.
    Leyck S; Parnham MJ
    Agents Actions; 1990 Jun; 30(3-4):426-31. PubMed ID: 2117337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenium: nutritional implications and prospects for therapeutic medicine.
    Fox JM
    Methods Find Exp Clin Pharmacol; 1992 May; 14(4):275-87. PubMed ID: 1507930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.